A comparison between MAL and UAL‐derived AD‐MSCs did not indicate significant changes in the expression of MSC markers (CD13, CD29, CD73, CD90, CD105; only the level of CD166 was higher in UAL‐derived cells). This evidence concerns the gene THY1 and Alzheimer disease.